High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (65 years) myeloma patients: comparison with younger patients treated on the same protocol

✍ Scribed by Jantunen, E; Kuittinen, T; Penttilä, K; Lehtonen, P; Mahlamäki, E; Nousiainen, T

• Book ID: 110014989
• Publisher: Nature Publishing Group
• Year: 2006
• Tongue: English
• Weight: 135 KB
• Volume: 37
• Category: Article
• ISSN: 0007-1188
• DOI: 10.1038/sj.bmt.1705360